Here's why GI Dynamics Inc crashed 60% today

GI Dynamics Inc (ASX:GID) showed just how risky the biotechnology industry can be.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medical device maker GI Dynamics Inc (ASX: GID) has emerged from a trading halt today, plummeting by as much as 60% to just 12 cents per share in the process.

The trading halt had been requested pending a "material announcement" regarding its business, GI Dynamics announced today that the US Food and Drug Administration (FDA) had put a hold on enrolment in the company's ongoing pivotal clinical trial of EndoBarrier in the US.

So What: GI Dynamics is focused on the development of non-surgical treatments for type 2 diabetes and obesity and EndoBarrier is one of its major products. While shipments of EndoBarrier were disrupted late last year, the FDA's decision comes as yet another setback for GI Dynamics and its shareholders.

According to the release, the FDA's decision came after four cases of bacterial infection in the liver among the 325 subjects currently enrolled in the trial. The bacterial infection, known as hepatic abscess, was known to be related to the treatment and has occurred on a higher-than-anticipated rate. Subsequently, the FDA has requested more information to further assess the treatment's risk/benefit profile.

Now What: The market's reaction today is a perfect example of how risky the biotechnology industry is. While the profits can be amazing when things go right (queue Sirtex Medical Limited (ASX: SRX)), enormous losses can also be suffered whenever the company experiences a setback.

A much safer way to make money on the stock market is to invest in high-quality businesses with enormous growth potential. Our top analyst has recently named his top stock pick for 2015, which is actually an ultra-promising tech company well worth checking out.

NEW: The Motley Fool's top stock for 2015 – Yours FREE!

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »